
Opinion|Videos|July 16, 2024
Managing Evaporative Dry Eye with New FDA-Approved Therapy
Experts provide clinical insights on the first FDA-approved treatment for evaporative dry eye, perfluorohexyloctane ophthalmic solution (MEIBO).
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- We now have the first FDA-approved treatment for evaporative dry eye [perfluorohexyloctane ophthalmic solution (MIEBO)]. What is significant about this new treatment?
- Why do we need to target evaporative dry eye specifically?
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Takeaways from this week in optometry: October 27 - October 31
2
Regeneron receives another CRL for its Eylea 8 mg
3
AAOpt 2025 recap: ODs provide new clinical findings on dry eye
4
Application period opens for 2026 Golden Opportunity Award to support emerging optometrists
5
















































.png)


